ORENITRAM Trademark

Trademark Overview

On Tuesday, October 16, 2012, a trademark application was filed for ORENITRAM with the United States Patent and Trademark Office. The USPTO has given the ORENITRAM trademark a serial number of 85755001. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, August 10, 2024. This trademark is owned by United Therapeutics Corporation. The ORENITRAM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used in the treatment of cardiovascular, cardiopulmonary, pulmonary, and vascular diseases; pharmaceutical preparations for the treatment of pulmonary hypertension
orenitram

General Information

Serial Number85755001
Word MarkORENITRAM
Filing DateTuesday, October 16, 2012
Status800 - REGISTERED AND RENEWED
Status DateSaturday, August 10, 2024
Registration Number4548443
Registration DateTuesday, June 10, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations used in the treatment of cardiovascular, cardiopulmonary, pulmonary, and vascular diseases; pharmaceutical preparations for the treatment of pulmonary hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 19, 2012
Primary Code005
First Use Anywhere DateThursday, April 3, 2014
First Use In Commerce DateThursday, April 3, 2014

Trademark Owner History

Party NameUnited Therapeutics Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameUnited Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameUnited Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910

Trademark Events

Event DateEvent Description
Friday, October 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 19, 2012NEW APPLICATION ENTERED
Monday, October 21, 2013SOU EXTENSION 1 GRANTED
Wednesday, February 13, 2013ASSIGNED TO EXAMINER
Tuesday, February 19, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 26, 2013PUBLISHED FOR OPPOSITION
Tuesday, March 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 21, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 21, 2013SOU TEAS EXTENSION RECEIVED
Monday, October 21, 2013SOU EXTENSION 1 FILED
Wednesday, October 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 28, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, April 4, 2014TEAS STATEMENT OF USE RECEIVED
Friday, April 4, 2014SOU TEAS EXTENSION RECEIVED
Friday, April 4, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 4, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 4, 2014SOU EXTENSION 2 FILED
Monday, April 28, 2014SOU EXTENSION 2 GRANTED
Friday, April 4, 2014USE AMENDMENT FILED
Wednesday, April 23, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 10, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, April 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 30, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 3, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 10, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 2, 2020TEAS SECTION 8 & 15 RECEIVED
Friday, August 21, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, August 21, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 21, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, June 10, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, August 10, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, August 10, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, August 10, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, August 10, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, May 23, 2024TEAS SECTION 8 & 9 RECEIVED

Related Keywords

orenitram pulmonary pharmaceutical treatment preparations diseases hypertension vascular cardiovascular used cardiopulmonary